1. Home
  2. ALGS vs ACFN Comparison

ALGS vs ACFN Comparison

Compare ALGS & ACFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGS
  • ACFN
  • Stock Information
  • Founded
  • ALGS 2018
  • ACFN 1986
  • Country
  • ALGS United States
  • ACFN United States
  • Employees
  • ALGS N/A
  • ACFN N/A
  • Industry
  • ALGS Biotechnology: Pharmaceutical Preparations
  • ACFN Military/Government/Technical
  • Sector
  • ALGS Health Care
  • ACFN Consumer Discretionary
  • Exchange
  • ALGS Nasdaq
  • ACFN Nasdaq
  • Market Cap
  • ALGS 53.0M
  • ACFN 62.5M
  • IPO Year
  • ALGS 2020
  • ACFN N/A
  • Fundamental
  • Price
  • ALGS $11.34
  • ACFN $27.62
  • Analyst Decision
  • ALGS Strong Buy
  • ACFN
  • Analyst Count
  • ALGS 2
  • ACFN 0
  • Target Price
  • ALGS $60.00
  • ACFN N/A
  • AVG Volume (30 Days)
  • ALGS 74.9K
  • ACFN 28.8K
  • Earning Date
  • ALGS 11-05-2025
  • ACFN 11-06-2025
  • Dividend Yield
  • ALGS N/A
  • ACFN N/A
  • EPS Growth
  • ALGS N/A
  • ACFN 1520.82
  • EPS
  • ALGS N/A
  • ACFN 2.84
  • Revenue
  • ALGS $3,174,000.00
  • ACFN $13,202,000.00
  • Revenue This Year
  • ALGS N/A
  • ACFN N/A
  • Revenue Next Year
  • ALGS $28.79
  • ACFN N/A
  • P/E Ratio
  • ALGS N/A
  • ACFN $9.74
  • Revenue Growth
  • ALGS N/A
  • ACFN 50.98
  • 52 Week Low
  • ALGS $3.76
  • ACFN $17.22
  • 52 Week High
  • ALGS $46.80
  • ACFN $33.00
  • Technical
  • Relative Strength Index (RSI)
  • ALGS 70.84
  • ACFN N/A
  • Support Level
  • ALGS $10.01
  • ACFN N/A
  • Resistance Level
  • ALGS $10.86
  • ACFN N/A
  • Average True Range (ATR)
  • ALGS 0.97
  • ACFN 0.00
  • MACD
  • ALGS 0.13
  • ACFN 0.00
  • Stochastic Oscillator
  • ALGS 90.81
  • ACFN 0.00

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

About ACFN Acorn Energy Inc. Common Stock

Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.

Share on Social Networks: